Approvals/NMPA/Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine and Haemophilus type b conjugate vaccine, adsorbed

Approved

生物制品

Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine and Haemophilus type b conjugate vaccine, adsorbed

SANOFI PASTEUR S.A.🇨🇳 National Medical Products Administration

Approval Date: Jul 30, 2015
Approval ID: 81u6FgZwLZu
Company: SANOFI PASTEUR S.A.
Type: 生物制品

Approval Details

Approval Id: 81u6FgZwLZu
Approval Number: J20150107
Generic Name: 吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌(结合)联合疫苗
Generic Name En: Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine and Haemophilus type b conjugate vaccine, adsorbed
Trade Name: 潘太欣
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 本品为两个包材包装,其一为百白破脊髓灰质炎疫苗,混悬液,每支0.5ml;其二为b型流感嗜血杆菌结合疫苗,冻干粉。使用前两者混合。其中百白破脊髓灰质炎疫苗含:无细胞百日咳疫苗效价不低于4.0IU;白喉疫苗效价不低于30IU;破伤风疫苗效价不低于40IU;1型灭活脊髓灰质炎病毒40DU,2型灭活脊髓灰质炎病毒8DU,3型灭活脊髓灰质炎病毒32DU;b型流感嗜血杆菌结合疫苗含与破伤风类毒素结合的b型流感嗜血杆菌多糖10μg
Reg Date: 2015-07-30
Company Name: SANOFI PASTEUR S.A.
Company Address: 2, avenue Pont Pasteur, 69007 LYON, FRANCE
Production Company Name: SANOFI PASTEUR S.A.
Production Company Address: 1541, avenue Marcel Merieux，69280 MARCY L'ETOILE
Company Detail Path: /organization/sanofi-pasteur-s-a
Production Company Detail Path: /organization/sanofi-pasteur-s-a

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 30, 2015

Approval ID

81u6FgZwLZu

Type

生物制品

Back to NMPA Approvals